Cargando…
Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma
BACKGROUND: Using guinea pig tracheal preparations, we have recently shown that endogenous arginase activity attenuates inhibitory nonadrenergic noncholinergic (iNANC) nerve-mediated airway smooth muscle relaxation by reducing nitric oxide (NO) production – due to competition with neuronal NO-syntha...
Autores principales: | Maarsingh, Harm, Leusink, John, Bos, I Sophie T, Zaagsma, Johan, Meurs, Herman |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1363345/ https://www.ncbi.nlm.nih.gov/pubmed/16409620 http://dx.doi.org/10.1186/1465-9921-7-6 |
Ejemplares similares
-
Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation
por: Maarsingh, Harm, et al.
Publicado: (2005) -
Recent Patents in Allergy/Immunology: Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
por: Meurs, Herman, et al.
Publicado: (2019) -
The laminin β1-competing peptide YIGSR induces a hypercontractile, hypoproliferative airway smooth muscle phenotype in an animal model of allergic asthma
por: Dekkers, Bart GJ, et al.
Publicado: (2010) -
Arginase and pulmonary diseases
por: Maarsingh, Harm, et al.
Publicado: (2008) -
Epac as a novel effector of airway smooth muscle relaxation
por: Roscioni, Sara S, et al.
Publicado: (2011)